Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease schizophrenia
Phenotype C0005586|bipolar disorder
Sentences 28
PubMedID- 21276242 The impairments were most marked in schizophrenia, while patients with bipolar disorder showed an intermediate degree of response relative to schizophrenia and healthy controls.
PubMedID- 26170741 Aripiprazole (ari, 7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1h)-one) is a commonly prescribed atypical antipsychotic drug used to treat psychosis such as schizophrenia, episodes associated with bipolar disorder, delayed sleep phase syndrome, and irritability in children with autism [12].
PubMedID- 22832610 In addition, il-6 release was significantly greater in bipolar disorder compared with schizophrenia patients (p<0.001).
PubMedID- 22927673 This study examined the diagnostic efficiency of p50 and p300 in schizophrenia as compared with healthy and bipolar disorder samples.
PubMedID- 25182665 Altered coupling of regional cerebral blood flow and brain temperature in schizophrenia compared with bipolar disorder and healthy subjects.
PubMedID- 24365456 We also found that current cognitive ability, measured by a speed of information processing task, was significantly lower in schizophrenia compared with both bipolar disorder with psychosis and depressive psychosis.
PubMedID- 24765654 Olanzapine is an atypical antipsychotic agent used to treat both negative and positive symptoms of schizophrenia, acute mania with bipolar disorder, agitation, and psychotic symptoms in dementia.9 according to biopharmaceutical classification system (bcs), olz is classified as a class ii drug (low solubility, high permeability) with water solubility around 43 mg/l.10 olz has been suggested to crystallize in more than 50 different crystalline forms, including anhydrates, hydrates, and solvates.11,12 in this study, anhydrous olz form i, the most stable form and currently used in pharmaceutical formulations, was selected for study.
PubMedID- 25912543 Only a few studies have directly compared the iq levels of schizophrenia patients with those of bipolar disorder patients; the majority of studies have compared schizophrenic patients against the general population.
PubMedID- 20021321 In such patients, a high inflammatory set point of circulating monocytes at the transcriptome level is observed, involving various inflammatory transcripts forming distinct fingerprints (the transcriptomic monocyte fingerprint in schizophrenia overlaps with that in bipolar disorder, but also differs with it at points).
PubMedID- 26189466 Comparing cohort incidence of schizophrenia with that of bipolar disorder and affective psychosis in individuals born in stockholm county 1955-1967.
PubMedID- 25017619 Metacognition in psychosis: comparison of schizophrenia with bipolar disorder.
PubMedID- 25936425 However, approximately twice as many cases eventuallyreceive a diagnosis of schizophrenia compared with bipolar disorder.
PubMedID- 25885525 There is also a dearth of evidence on the functional outcomes of severe mental disorders aside from schizophrenia, including bipolar disorder and depression with psychotic features, in lamics.
PubMedID- 22580710 Given the phenotypic and genetic overlap of schizophrenia with bipolar disorder [40], the present results support existing evidence that genetic variation of dtnbp1 may not only be a risk factor for schizophrenia, but also play a role in a broader context of psychiatric disorders including affective psychoses.
PubMedID- 24944580 For example, schizophrenia is treated with antipsychotics, bipolar disorder with mood stabilizers and antipsychotics, major depression with antidepressants and adhd with psychostimulants (table 1).
PubMedID- 22815915 Olanzapine (db00334) approved in 1996, is an atypical antipsychotic agent, which is used to treat both negative and positive symptoms of schizophrenia, acute mania with bipolar disorder, agitation, and psychotic symptoms in dementia [38], [46].
PubMedID- 23974872 Paper had aparticular focus contrasting schizophrenia with bipolar disorder and reportedgwas results from sw1-4 (n=4044, 42.6% of the full sample).75 thus, of the totalsample of 11,850 swedish subjects before quality control (5,351 cases, 6,509controls), 57.4% have never been reported previously.
PubMedID- 25217364 Diagnostic transition towards schizophrenia in adolescents with severe bipolar disorder type i: an 8-year follow-up study.
PubMedID- 26299707 There is little evidence that memory impairments in schizophrenia are shared with bipolar disorder and adhd.
PubMedID- 26142890 This early-response phenomenon has been observed in the treatment of schizophrenia with antipsychotics [6–10], bipolar disorder with antidepressants [11], major depressive disorder with antidepressants [12], attention-deficit/hyperactivity disorder with a selective norepinephrine reuptake inhibitor [13, 14], plaque psoriasis with monoclonal antibody therapy [15], rheumatoid arthritis with monoclonal antibody therapy [16], and breast cancer with neoadjuvant chemotherapy [17].
PubMedID- 24061607 For our purpose, we administered a modern and multi-purpose neuropsychological task paradigm to equal-sized and matched groups of schizophrenia patients, patients with bipolar disorder, and healthy control subjects.
PubMedID- 22967188 In addition, increases in blood glucose, total cholesterol and triglyceride levels were higher in the schizophrenia group compared with the bipolar disorder group, even though these differences were not statistically significant.
PubMedID- 25616505 Meta-analysis of cognitive impairment in first-episode bipolar disorder: comparison with first-episode schizophrenia and healthy controls.
PubMedID- 21653945 Results: individuals with bipolar disorder and healthy siblings of people with schizophrenia or bipolar disorder were overrepresented in creative professions.
PubMedID- 22688191 Genome-wide association study in a swedish population yields support for greater cnv and mhc involvement in schizophrenia compared with bipolar disorder.
PubMedID- 22704340 Similar results were also found in the basal ganglia of patients with schizophrenia but not in patients with bipolar disorder (veldic et al.
PubMedID- 23529008 Furthermore, the present investigation further showed that these reductions are specific to schizophrenia, as patients with bipolar disorder exhibit prefrontal cortical synapsin ii mrna expression levels comparable to those observed in control subjects.
PubMedID- 19891810 The aim of this study was to investigate the association between cannabis use and neurocognition in bipolar disorder compared with schizophrenia in a naturalistic setting.

Page: 1